Epstein-Barr Virus-Associated Lymphoma Developed Shortly After Immunosuppressive Treatment for Ulcerative Colitis

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 4, 2007, Pages 521-

  Akamatsu, Takuji ^a   Watanabe, Norihiko ^a   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

B CELL LYMPHOMA; CASE REPORT; ENTERITIS; EPSTEIN BARR VIRUS; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LYMPHOCYTE PROLIFERATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; RISK FACTOR; SERODIAGNOSIS; TRANSPLANTATION; TREATMENT DURATION; ULCERATIVE COLITIS; VIRUS INFECTION;

COLITIS, ULCERATIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, B-CELL; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 34147159686     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2007.02.003     Document Type: Letter

References (3)

1. Schwartz L.K., Kim K.M., Coleman M., et al. Case report: lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol 4 (2006) 1030-1034
2. Hopwood P., and Crawford D.H. The role of EBV in post-transplant malignancies: a review. J Clin Pathol 53 (2000) 248-254
3. Dayharsh G.A., Loftus Jr. E.V., Sandborn W.J., et al. Epstein-Barr virus positive lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine. Gastroenterology 122 (2002) 72-77